Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer.

Nishio M, Hida T, Atagi S, Sakai H, Nakagawa K, Takahashi T, Nogami N, Saka H, Takenoyama M, Maemondo M, Ohe Y, Nokihara H, Hirashima T, Tanaka H, Fujita S, Takeda K, Goto K, Satouchi M, Isobe H, Minato K, Sumiyoshi N, Tamura T.

Open source

DOI: 10.1136/esmoopen-2016-000108
Published: 2016-01-01
Container: ESMO Open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/esmoopen-2016-000108,
  title = {Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer.},
  author = {Nishio M and  Hida T and  Atagi S and  Sakai H and  Nakagawa K and  Takahashi T and  Nogami N and  Saka H and  Takenoyama M and  Maemondo M and  Ohe Y and  Nokihara H and  Hirashima T and  Tanaka H and  Fujita S and  Takeda K and  Goto K and  Satouchi M and  Isobe H and  Minato K and  Sumiyoshi N and  Tamura T.},
  year = {2016},
  journal = {ESMO Open},
  doi = {10.1136/esmoopen-2016-000108},
  url = {https://doi.org/10.1136/esmoopen-2016-000108}
}

RIS

TY  - JOUR
TI  - Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer.
AU  - Nishio M
AU  -  Hida T
AU  -  Atagi S
AU  -  Sakai H
AU  -  Nakagawa K
AU  -  Takahashi T
AU  -  Nogami N
AU  -  Saka H
AU  -  Takenoyama M
AU  -  Maemondo M
AU  -  Ohe Y
AU  -  Nokihara H
AU  -  Hirashima T
AU  -  Tanaka H
AU  -  Fujita S
AU  -  Takeda K
AU  -  Goto K
AU  -  Satouchi M
AU  -  Isobe H
AU  -  Minato K
AU  -  Sumiyoshi N
AU  -  Tamura T.
PY  - 2016
JO  - ESMO Open
DO  - 10.1136/esmoopen-2016-000108
UR  - https://doi.org/10.1136/esmoopen-2016-000108
ER  -

APA

M, N., T, H., S, A., H, S., K, N., T, T., N, N., H, S., M, T., M, M., Y, O., H, N., T, H., H, T., S, F., K, T., K, G., M, S., H, I., K, M., N, S., & T., T. (2016). Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer.. ESMO Open. https://doi.org/10.1136/esmoopen-2016-000108

Source records

europe-pmc · retrieved 2026-09-27T12:24:31.582Z